rs121908305
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PP2PP5_Very_Strong
The NM_000157.4(GBA1):c.1090G>A(p.Gly364Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,836 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. G364G) has been classified as Likely benign.
Frequency
Consequence
NM_000157.4 missense
Scores
Clinical Significance
Conservation
Publications
- Parkinson diseaseInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Gaucher diseaseInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
- Gaucher disease perinatal lethalInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
- late-onset Parkinson diseaseInheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Gaucher disease type IInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
- Gaucher disease type IIInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- Gaucher disease type IIIInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
- Gaucher disease-ophthalmoplegia-cardiovascular calcification syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GBA1 | NM_000157.4 | c.1090G>A | p.Gly364Arg | missense_variant | Exon 8 of 11 | ENST00000368373.8 | NP_000148.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251418 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461836Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 727232 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Gaucher disease type II;C0268251:Gaucher disease type III;C0752347:Lewy body dementia;C1842704:Gaucher disease perinatal lethal;C1856476:Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;C1961835:Gaucher disease type I;C3160718:Parkinson disease, late-onset Pathogenic:1
- -
not provided Pathogenic:1
- -
Gaucher disease type II Pathogenic:1
- -
Gaucher disease Pathogenic:1
The p.Gly364Arg variant in GBA has been reported in at least 3 individuals with Gaucher disease (PMID: 30497978, 25435509, 29685539) and has been Identified in 0.006% (2/34580) of Latino chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs121908305). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (VariationID: 4318) as pathogenic by OMIM and as likely pathogenic by EGL Genetic Diagnostics. In vitro functional studies provide some evidence that the p.Gly364Arg variant may impact protein function (PMID: 30497978). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. One additional likely pathogenic variant, resulting in a different amino acid change at the same position, p.Arg364Trp, has been reported in association with disease in the literature, slightly supporting that a change at this position may not be tolerated (PMID: 17427031, 11259172). In addition, The presence of this variant in in combination with a reported pathogenic variant and in an individual with Gaucher disease increases the likelihood that the p.Gly364Arg variant is pathogenic (VariationID: 4319; PMID: 28727984, 30497978). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PM2, PS3_moderate, PM3, PM5_supporting (Richards 2015). -
Gaucher disease perinatal lethal Pathogenic:1
This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PS3,PM2,PP2,PP3. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at